| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.4M | -88.2% |
| Cost of Revenue | $2.0M | -87.7% |
| Gross Profit | $394K | -90.2% |
| R&D Expense | $174K | +1293.8% |
| SG&A Expense | $7.9M | -64.9% |
| Operating Income | -$8.4M | +74.8% |
| Interest Expense | $0 | — |
| Pre-tax Income | -$9.0M | +74.7% |
| Income Tax | $1K | -99.5% |
| Net Income | -$13.7M | +60.9% |
| EPS (Basic) | -$0.02 | +60.0% |
| EPS (Diluted) | -$0.02 | +60.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.2M | -52.3% |
| Current Assets | $2.0M | -81.7% |
| Total Assets | $10.0M | -63.0% |
| Current Liabilities | $8.8M | -28.8% |
| Long-term Debt | $0 | — |
| Total Liabilities | $121.7M | -0.7% |
| Stockholders' Equity | -$106.0M | -11.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $3K | +0.0% |
| Financing Cash Flow | $6.9M | +46.1% |